MedTrace Logo

Tampere Coronary Artery Disease and Sudden Cardiac Arrest Study

NCT06804499 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2025-02-03

No results posted yet for this study

Summary

The goal of this observational study is to recognize clinical and genetic risk factors for sudden cardiac arrest (SCA) and death (SCD) in patients with coronary artery disease (CAD).

The main questions it aims to answer are:

Are we able to recognize clinical or treatment-related risk factors for SCA or SCD? Can we identify new genetic risk factors for SCA or SCD in patients under 75 years?

Participants diagnosed with CAD answer a short survey about their medical history and socioeconomic status. A standard ECG addition to a five (5) minute ECG recording is taken from all the study subjects. In addition to a few short physiological tests (e.g. blood pressure, height, weight, grip strength), a blood sample is withdrawn from a selected group of study subjects.

Medical healthcare records are used to follow all study subjects, and no follow-up visits are required.

Conditions

  • Sudden Cardiac Arrest
  • Sudden Cardiac Death
  • Sudden Cardiac Death Due to Cardiac Arrhythmia
  • Coronary Arterial Disease (CAD)
  • Acute Coronary Event

Sponsors & Collaborators

  • Tampere University

    collaborator OTHER

  • Tampere University Hospital

    collaborator OTHER

  • Tampere Heart Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2027-12-31
Completion
2042-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06804499 on ClinicalTrials.gov